The Rural 340B Access Act of 2025 amends section 340B(a)(4) of the Public Health Service Act to designate rural emergency hospitals (REHs) as covered entities for the 340B drug discount program. The amendment adds a new subparagraph that admits REHs that meet the Social Security Act definition and are owned or operated by state/local governments, are public or private non‑profit corporations granted governmental powers, or are private non‑profit REHs with a contract to provide care to low‑income individuals not entitled to Medicare or eligible for Medicaid.
This change directly extends 340B outpatient drug discounts to a distinct, recently created rural hospital category. That expands the program’s reach into rural areas and creates immediate compliance, verification, and program‑integrity implications for REHs, HRSA (which administers 340B), drug manufacturers, and state and local governments that contract with these facilities.
At a Glance
What It Does
The bill inserts a new subparagraph (P) into 42 U.S.C. 256b(a)(4) to treat rural emergency hospitals as 340B covered entities when they meet the Social Security Act’s REH definition and specified ownership or contract conditions. It does not amend other 340B eligibility rules.
Who It Affects
Rural emergency hospitals (public and qualifying non‑profit private REHs), state and local governments that own or contract with REHs, HRSA as program administrator, and pharmaceutical manufacturers that supply outpatient drugs to 340B entities.
Why It Matters
Bringing REHs into 340B channels discounts outpatient drug costs for rural safety‑net providers, potentially lowering care costs or supporting other services, while shifting discount obligations to manufacturers and adding verification and audit duties to HRSA and covered entities.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill makes a single, targeted change to the 340B statute: it adds rural emergency hospitals to the list of entities eligible for 340B discounted drugs. It does this by adding a new subparagraph to the existing covered‑entity list in section 340B(a)(4), and it imports the statutory REH definition from the Social Security Act (section 1861(kkk)(2)).
That means only facilities that qualify as REHs under Medicare law can be treated as covered entities under 340B.
Eligibility is not blanket; the bill limits which REHs qualify by ownership and contractual relationships. Publicly owned or operated REHs and public or private non‑profit corporations that have been formally granted governmental powers are eligible.
Separately, private non‑profit REHs can qualify only if they have a contract with a state or local government to provide care to low‑income individuals who are not entitled to Medicare or eligible for Medicaid under a State plan. Those ownership and contract conditions will shape which rural hospitals can enroll and claim 340B discounts.Operationally, the change creates immediate administrative tasks.
HRSA will continue to run 340B registration, oversight, and audits; it will need to adapt registration rules and documentation checks to account for the REH definition and the contract/ownership categories the bill specifies. Covered entities and manufacturers will need to update compliance processes: REHs must prepare to document ownership status or contracts and manage 340B program safeguards (eligible patient definitions, dispensing records, and audit readiness), while manufacturers will face expanded discount obligations when supplying outpatient drugs to qualifying REHs.For rural patients, the practical effect is expanded access to discounted outpatient drugs through certain REHs, which may translate into lower out‑of‑pocket costs or freed resources for other services.
For state and local governments, the bill makes their ownership decisions and contracting arrangements pivotal to whether a rural hospital can access 340B savings, introducing a policy lever for expanding support to rural care providers.
The Five Things You Need to Know
The bill amends 42 U.S.C. 256b(a)(4) by adding a new subparagraph (P) that treats rural emergency hospitals as 340B covered entities.
It ties eligibility to the Social Security Act’s REH definition (section 1861(kkk)(2)), so only facilities that meet that Medicare definition can qualify.
Eligible REHs include those owned or operated by state or local governments and public or private non‑profit corporations formally granted governmental powers.
Private non‑profit REHs without governmental ownership qualify only if they have a contract with a state or local government to serve low‑income individuals who are not entitled to Medicare or eligible for Medicaid.
The bill is narrowly additive: it does not change other 340B eligibility categories or alter the core statutory 340B framework beyond adding REHs.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s short name: the "Rural 340B Access Act of 2025." This is purely captioning language and has no operative legal effect beyond identifying the statute by name.
Add rural emergency hospitals to the covered‑entity list
Makes the operative change by inserting subparagraph (P) into section 340B(a)(4) of the Public Health Service Act. Practically, this instructs HRSA and stakeholders that REHs, when they meet the specified criteria, become eligible to purchase outpatient drugs under 340B discount arrangements. The amendment is limited to the 340B statute; it does not add new reporting requirements in the bill text itself, nor does it modify other 340B eligibility rules.
Defines which REHs qualify using existing Social Security Act language and ownership/contract tests
The added text imports the REH definition from section 1861(kkk)(2) of the Social Security Act and then sets ownership and contract conditions that determine qualification. The text distinguishes public ownership/operation and entities with governmental powers from private non‑profits that must hold a government contract to serve low‑income, non‑Medicare/non‑Medicaid individuals. That structure creates different documentary burdens depending on a facility’s legal form and the existence of explicit contracts with state or local governments.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Rural emergency hospitals that meet the REH definition and ownership/contract criteria — they gain access to 340B outpatient drug discounts, which can lower pharmacy costs or free up resources for other services.
- Low‑income rural patients served by qualifying REHs — they may experience reduced out‑of‑pocket costs for outpatient prescription drugs or expanded local services funded by 340B savings.
- State and local governments that contract with private non‑profit REHs — contracting becomes a practical lever to extend 340B benefits to local providers and preserve rural access to care.
- Community health systems and rural health coalitions — they can integrate newly eligible REHs into regional care and pharmacy networks, potentially improving coordinated outpatient drug provisioning.
Who Bears the Cost
- Pharmaceutical manufacturers — extending 340B eligibility increases the volume of discounted outpatient drugs they must provide, which affects pricing and internal compliance for manufacturer 340B programs.
- Qualifying REHs — while they gain discounts, REHs will face new administrative burdens (registration, documentation of eligibility, patient eligibility tracking, and audit readiness) that can strain small hospital staff.
- HRSA and program administrators — the agency will need to update registration, verification, and oversight procedures to accommodate REH registrations and to adjudicate documentation of ownership or contracts.
- State and local governments — if governments wish to enable private non‑profit REHs to access 340B, they may need to negotiate or maintain contracts specifying care to low‑income, non‑Medicare/non‑Medicaid populations, potentially increasing budgetary or administrative commitments.
Key Issues
The Core Tension
The bill balances two legitimate goals: extending drug‑discount relief to fragile rural providers to preserve access versus preserving program integrity and predictable manufacturer obligations; expanding eligibility helps rural patients and providers but increases administrative and compliance complexity, shifting costs and verification burdens to HRSA, manufacturers, and local governments.
The bill is narrowly focused on eligibility, but that narrowness creates implementation complexity. Importing the REH definition from Medicare law ties 340B eligibility to an external statutory construct that includes facility certification, payment rules, and conditions distinct from 340B administration; HRSA will need to decide how to validate an REH’s Medicare status and reconcile timing differences between Medicare certification and 340B registration.
The ownership and contract conditions introduce multiple documentary paths to eligibility, which will require clear guidance to avoid inconsistent approvals or audit findings.
Program‑integrity tensions arise because expanding 340B’s footprint increases the volume of discounted drugs in circulation without any textual guardrails in the bill about how REHs must use savings or how to prevent duplicate discounts in Medicaid (an issue already central to 340B administration). Smaller REHs may lack the compliance infrastructure of larger safety‑net providers, raising audit risk and potential downstream disputes with manufacturers.
Finally, the contract requirement for private non‑profits hinges on a specific population test (low‑income individuals who are not eligible for Medicare or Medicaid), which may prove administratively hard to verify and could invite disputes over patient eligibility and contract sufficiency.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.